Dr. Granville provides insight, guidance, and a collaborative approach to build DIA’s thought leadership, research and content strategy to support innovation and building efficiency in drug, device and diagnostics development. She brings 2 decades of regulatory science-related research experience to her role at DIA. Her research career focused on developing data to support regulatory decision making in the fields of tobacco regulatory science, preclinical and molecular toxicology, nonclinical drug development, and public health. She holds a BS in Biology from Yale University, an MSPH in Environmental Health from UNC Chapel Hill and a PhD in Biochemistry and Molecular Genetics from George Washington University.

Leonid Shylovskiy is a clinical pharmacist and legal counsel for clinical trials industry in Ukraine. He is acts as a CRA, regulatory affairs expert, recruiter and start up specialist of healthcare research projects such as clinical trials related to cancer and other disorders as Crohn’s disease and ulcerative colitis, among others. A typical example of his work is protocol 2021L001 for testing a COVID vaccine, which was carried out in 2021 in Ukraine and covered 10,000 healthy volunteers. Additionally, Dr. Shylovskiy has similar experience in an oncology study that was approved in 2020 and continued in Ukraine in 2021.

Igor Bondarenko is the head of Oncology and Medical Radiology Department of Dnipropetrovsk Medical Academy (Ukraine) since 2000. Igor Bondarenko has created the first in Ukraine center for clinical trials, where oncology treatment is provided by international partners. He was the principal investigator in 482 clinical trials. The total amount of patients, participated in clinical trials, was more than 4800, the number of investigated drugs is more than 250.

Richard is Professor of Cancer and Global Health at King’s College London and Guy’s Comprehensive Cancer Centre. He is director of the Institute of Cancer Policy and the Centre for Conflict & Health Research. His global cancer research covers cancer systems strengthening, financing, political economy, global radiotherapy, VR enhanced surgical simulation training, social welfare and cancer care in conflict. He has research interests in conflict and health with a special focus on the Middle East. Professor Sullivan trained in surgery gaining his PhD in Biochemistry from University College London. Richard was formally Clinical Director of Cancer Research UK for nearly ten years and a consultant surgeon by background.

Dr. Stakhovskyi graduated from the National Medical University in Kyiv in 2004. Completed his residency in urology in Kiev Medical Academy of Postgraduate Education named after I.P Schupik and Institute of Urology in 2008. Dr.Stakhovskyi did a 6 months clinical fellowship in Laparoscopic Urological Surgery in Institute Mutualiste Montsouris, Paris (2009) and from 2010-2012 completed UroOncology fellowship in University of Toronto, Canada. He has been working in theNational Cancer Institute from 2012 till present.